Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 12,929 shares at $18.20 ($236K) on 2025-08-07, disclosed to the SEC on 2025-08-11.
Scheduled sale ($236k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.20 | 6,262 | $114K | 48.4% |
| 2 | $18.20 | 6,262 | $114K | 48.4% |
| 3 | $18.93 | 405 | $8K | 3.3% |
| Total | $18.22 avg | 12,929 | $236K | 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |